Project Grant R01DE034408
- Summary of Federal Project Grant Award The National Institute of Dental and Craniofacial Research awarded $736,507 to The University of Texas MD Anderson Cancer Center under the Oral Diseases and Disorders Research program (CFDA 93.121) to support the OPULENCE (Ontology-Based Applications of Multi-Disciplinary Knowledge on Orodental Conditions and Outcomes) project. The award, effective August 1, 2025, through May 31, 2030, funds a multi-institutional and multidisciplinary research initiative...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Texas Health Science Center at San Antonio a $315,000 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 20, 2025, with a completion date of August 19, 2027. The award supports a two-year research initiative titled "Targeting TRPC1: A Novel Approach to Treat Oral Cancer," which addresses the significant clinical need for...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded the University of Michigan a Project Grant totaling $219,660 (awarded January 1, 2029) under the Oral Diseases and Disorders Research program (CFDA 93.121) to support research investigating the evolution of pro-tumoral myeloid cells during the initiation of oral cancer. The research focuses on understanding how SOX2-driven genetic alterations in human papillomavirus-negative head and neck squamous cell...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Texas Health Science Center at San Antonio $1,309,466 through the Oral Diseases and Disorders Research program (CFDA 93.121) on August 13, 2025, to conduct research on the role of truncated TrkB isoform (TrkBT1) in oral cancer pain. The award supports a four-year research initiative extending through May 31, 2029, focused on investigating how the truncated TrkB...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research awarded a $421,625 Project Grant to Texas A&M Engineering Experiment Station (Tees) on July 1, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support advanced preclinical research on oral squamous cell carcinoma (OSCC). The primary deliverables involve the development and engineering of innovative tumor microenvironment chips (TME-chips) that incorporate functional...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $104,506 on March 5, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to support a research project titled "Single-Cell Profiling of Follistatin Within the Tumor Landscape of Oral Squamous Cell Carcinoma." The Research Foundation for the State University of New York, serving as the fiscal and administrative agent, will oversee execution of this...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $716,123 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective September 8, 2025 through May 31, 2030. The award supports research focused on developing ultrasensitive detection methodologies for circulating DNA methylation biomarkers in head and neck squamous cell...
- Federal Project Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The Leland Stanford Junior University a $308,223 Project Grant effective July 15, 2025, through July 14, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). This award supports basic and translational research investigating the role of ACTL6A gene expression in metabolic reprogramming and cancer stem cell maintenance within oral cavity squamous cell carcinoma...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $451,000 to The Regents of the University of California, San Francisco under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 8, 2025, for a two-year project concluding August 7, 2027. The award funds the development and characterization of metastatic MYB-NFIB fusion adenoid cystic carcinoma (ACC) cell line models to advance understanding of this rare but aggressive...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Texas Health Science Center at San Antonio a $622,744 Project Grant effective July 1, 2025, through March 31, 2030, under the Oral Diseases and Disorders Research program (CFDA 93.121). This research initiative investigates the role of TRPM2 (Transient Receptor Potential Melastatin 2), a calcium-permeable ion channel, in the pathogenesis of radiation-induced oral mucositis...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Texas MD Anderson Cancer Center a $735,436 Project Grant (CFDA 93.121: Oral Diseases and Disorders Research) effective March 1, 2026, through February 28, 2031, to conduct research on subclonal evolution and fitness dynamics in oral carcinogenesis. The research addresses a critical clinical need to improve risk stratification of oral premalignant lesions (OPLs), which affect approximately 70 million people worldwide and progress to oral squamous cell carcinoma (OSCC) in a subset of cases. The project will employ serial brush biopsy techniques and genomic analysis to identify and characterize the functional importance of genomic events—beyond early inactivation events—that drive subclonal selection and transformation from OPL to OSCC, with the hypothesis that copy number gains and oncogene activation promote subclonal diversity and competition leading to malignant transformation. The research deliverables will include comprehensive interrogation of the molecular mechanisms underlying oral carcinogenesis evolution, with findings intended to enhance current histopathologic risk assessment approaches and support improved clinical decision-making for early identification and removal of high-risk lesions. By leveraging orthogonal genomic and functional approaches, the project will generate knowledge to address the existing gap in understanding how sequential genomic events lead to selection of high-risk subclones, thereby advancing prevention and early detection strategies in oral cancer care.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $735.4k | 2/18/26 |